Apimeds Pharmaceuticals US, Inc. APUS
2.36 USD -0.33 (-12.27%)
At closeNov 11, 2026, 6:08 PM EST
2.47 +0.11 +4.66%
After hours · Nov 11, 6:08 PM ET
2.22 Day range 2.68
1.51 52-week range 59.70
- YTD
- -85.61%
- 1 year
- -91.16%
APUS revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | 0 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-07-25T06:01:17.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.